Fractionated radioimmunotherapy of B-cell malignancies with 131I-Lym-1. 1990

G L DeNardo, and S J DeNardo, and L F O'Grady, and N B Levy, and G P Adams, and S L Mills
Department of Internal Medicine, University of California, Davis Medical Center, Sacramento 95817.

Eighteen patients with Stage 4 B-cell malignancies, which were primarily of intermediate or high grade and progressive despite multiple drug chemotherapy and external irradiation, were treated with fractionated doses of 131I-labeled Lym-1. Lym-1 is an IgG2a monoclonal antibody that was produced by immunizing mice with Raji cell nuclei that originated from a patient with African Burkitt's lymphoma. Despite advanced disease, 10 of the patients had objective evidence for a complete or partial remission. Toxicity was very modest except in one patient who developed hypotension. Dose-dependent hepatic uptake of Lym-1 was observed in the patients and in BALB/c mice suggesting receptor-mediated recognition of this murine antibody.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000888 Antibodies, Anti-Idiotypic Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies. Anti-Antibodies,Anti-Idiotype Antibodies,Antibodies, Internal Image,Antigamma Globulin Antibodies,Antiglobulins,Anti Antibodies,Anti-gamma Globulin Antibodies,Anti Idiotype Antibodies,Anti gamma Globulin Antibodies,Anti-Idiotypic Antibodies,Antibodies, Anti,Antibodies, Anti Idiotypic,Antibodies, Anti-Idiotype,Antibodies, Anti-gamma Globulin,Antibodies, Antigamma Globulin,Globulin Antibodies, Anti-gamma,Globulin Antibodies, Antigamma,Image Antibodies, Internal,Internal Image Antibodies
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D015448 Leukemia, B-Cell A malignant disease of the B-LYMPHOCYTES in the bone marrow and/or blood. B-Cell Leukemia,B-Lymphocytic Leukemia,Leukemia, Lymphocytic, B-Cell,Lymphocytic Leukemia, B-Cell,Leukemia, Lymphocytic, B Cell,B Cell Leukemia,B Lymphocytic Leukemia,B-Cell Leukemias,B-Cell Lymphocytic Leukemia,B-Cell Lymphocytic Leukemias,B-Lymphocytic Leukemias,Leukemia, B Cell,Leukemia, B-Cell Lymphocytic,Leukemia, B-Lymphocytic,Leukemias, B-Cell,Leukemias, B-Cell Lymphocytic,Leukemias, B-Lymphocytic,Lymphocytic Leukemia, B Cell,Lymphocytic Leukemias, B-Cell

Related Publications

G L DeNardo, and S J DeNardo, and L F O'Grady, and N B Levy, and G P Adams, and S L Mills
January 1995, The International journal of biological markers,
G L DeNardo, and S J DeNardo, and L F O'Grady, and N B Levy, and G P Adams, and S L Mills
October 1997, Nuclear medicine and biology,
G L DeNardo, and S J DeNardo, and L F O'Grady, and N B Levy, and G P Adams, and S L Mills
August 1993, The New England journal of medicine,
G L DeNardo, and S J DeNardo, and L F O'Grady, and N B Levy, and G P Adams, and S L Mills
November 1988, Zhonghua zhong liu za zhi [Chinese journal of oncology],
G L DeNardo, and S J DeNardo, and L F O'Grady, and N B Levy, and G P Adams, and S L Mills
December 1995, Cancer research,
G L DeNardo, and S J DeNardo, and L F O'Grady, and N B Levy, and G P Adams, and S L Mills
January 1989, Hematological oncology,
G L DeNardo, and S J DeNardo, and L F O'Grady, and N B Levy, and G P Adams, and S L Mills
January 2023, Leukemia & lymphoma,
G L DeNardo, and S J DeNardo, and L F O'Grady, and N B Levy, and G P Adams, and S L Mills
November 2007, Current opinion in hematology,
G L DeNardo, and S J DeNardo, and L F O'Grady, and N B Levy, and G P Adams, and S L Mills
August 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
G L DeNardo, and S J DeNardo, and L F O'Grady, and N B Levy, and G P Adams, and S L Mills
October 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Copied contents to your clipboard!